Fludarabine Injection, Solution
Product Images NDC 63323-192

4 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fludarabine (NDC 63323-192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fludarabine-structure (Flu2w 0000 01)

Fludarabine-structure (Flu2w 0000 01)
Chemical structure of Fludarabine phosphate shown as a molecular diagram illustrating its chemical bonds and atomic arrangement.*
FDA Label Image

Logo (Flu2w 0000 02)

FDA Label Image

Vial (Flu2w 0000 03)

Vial (Flu2w 0000 03)
Fludarabine Phosphate Injection, Solution 50 mg per 2 mL (25 mg/mL) single-dose vial label. The product is for intravenous use only, preservative free, and contains a cytotoxic agent warning. Labeled by Fresenius Kabi USA, LLC with NDC 63323-192 included on the label.*
FDA Label Image

Carton (Flu2w 0000 04)

Carton (Flu2w 0000 04)
Fludarabine Phosphate Injection USP label showing strength of 25 mg per mL (50 mg per 2 mL) in a single-dose vial. The label states intravenous use only, preservative free, and highlights the product as a cytotoxic agent. The manufacturer is Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.